Neo-Naclex-K modified-release tablets (Mercury Pharma Group Ltd) (real clinical drug)
real clinical drugSupplier: uk-clinical · SCTID 3638211000001100
Actual medicinal product Bendroflumethiazide 2.5mg / Potassium chloride 630mg (potassium 8.4mmol) modified-release tablets Neo-Naclex-K